AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 266: E155-E160, 1994;
0193-1849/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Townsend, R. R.
Right arrow Articles by Wolfe, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Townsend, R. R.
Right arrow Articles by Wolfe, R. R.

AJP - Endocrinology and Metabolism, Vol 266, Issue 2 E155-E160, Copyright © 1994 by American Physiological Society


ARTICLES

Changes in lipolytic sensitivity following repeated epinephrine infusion in humans

R. R. Townsend, S. Klein and R. R. Wolfe
Department of Medicine, University of Texas Medical Branch, Galveston.

The lipolytic response to epinephrine is increased in lean but not obese subjects during conditions of increased circulating catecholamines such as starvation and critical illness. We evaluated the effect of repeated epinephrine treatment (0.03 micrograms.kg-1.min-1 for 30 min thrice daily) on basal lipolysis and the lipolytic response to epinephrine in lean and obese subjects. Lipolytic rates were determined using [2H5]glycerol during basal conditions and 60 min of epinephrine infusion before and after 6 days of repeated epinephrine treatment. Basal lipolysis and the lipolytic response to epinephrine were higher in obese (2.47 +/- 0.51 mumol.kg-1.min-1 and 106 +/- 21 mumol/kg, respectively) than lean (1.45 +/- 0.15 mumol.kg-1.min-1 and 70 +/- 12 mumol/kg, respectively; P = 0.08 obese vs. lean) subjects. Repeated epinephrine treatment decreased basal glycerol rate of appearance and the lipolytic response to epinephrine in lean and obese subjects. Plasma insulin concentration increased after repeated epinephrine treatment in both obese (14.3 +/- 0.6 to 18.2 +/- 1.6 microU/ml; P < 0.05) and lean (8.4 +/- 1.3 to 11.1 +/- 1.5 microU/ml; P < 0.01) subjects. Repeated epinephrine treatment suppresses basal and epinephrine-stimulated lipolysis. Increased plasma insulin concentration may be the mechanism.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online